Medisyn Technologies

	Medisyn's David Land Honored as Innovator of the Year Minneapolis, October 30, 2002 - Medisyn Technologies President David Land was honored as an Innovator of the Year by Finance & Commerce, a Twin Cities business daily at an award ceremony on September 23, 2002. David was recognized for embracing innovative technology and aggressively working towards commercialization. Medisyn is a Twin Citied-based biotechnology startup. About Medisyn Technologies Medisyn Technologies is a unique drug design and discovery company that uses proprietary technology to make drug discovery faster, more predictable and less expensive. Based on molecular topology, Medisyn’s Forward EngineeringTM platform enables the discovery and design of novel, diverse and unexpected compounds that meet exact parameters for a specific therapeutic use. By compressing design and discovery time from years to weeks and optimizing lead candidates, Medisyn’s novel approach enables drug discovery customers to reduce risk, improve probability of success and control costs associated with the traditional lead discovery process. The company is initially focused on treating cancer and is currently completing pre-clinical validation of MT103, a promising lead candidate for non-small cell lung cancer. It has an additional 26 anti-cancer compounds in varying stages of development. Medisyn Technologies is headquartered in Minneapolis, MN. For more information about Medisyn Technologies, visit the company’s website at: www.medisyntech.com or call 952.475.8084. Contact: Pam Pettinella LATITUDE 952.404.1853 pam@latitude-c.com Close Window